✦ LIBER ✦

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

✍ Scribed by Craig Anderson; Koon Teo; Peggy Gao; Hisatomi Arima; Antonio Dans; Thomas Unger; Patrick Commerford; Leanne Dyal; Helmut Schumacher; Janice Pogue; Ernesto Paolasso; Nicolaas Holwerda; Irina Chazova; Azan Binbrek; James Young; Salim Yusuf

Book ID: 114409644
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 335 KB
Volume: 10
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(10)70250-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ONTARGET: Does dual blockade of the reni

ONTARGET: Does dual blockade of the renin-angiotensin system provide more effective cardiovascular and renal protection in patients at high cardiovascular risk?

✍ Jean-Michel Halimi; Albert Mimran 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 200 KB

Single and dual blockade of the renin-an

Single and dual blockade of the renin-angiotensin system in high-risk patients without heart failure: Lessons from ONTARGET

✍ Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Chiara Dembech; Gianpaolo Reb 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 163 KB

Renin angiotensin aldosterone system blo

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study

✍ Kiyoshi Kurokawa; Juliana C.N. Chan; Mark E. Cooper; William F. Keane; Shahnaz S 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 653 KB

Sexual function, satisfaction, and assoc

Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND)

✍ Michael Böhm; Magnus Baumhäkel; Jeffrey L. Probstfield; Roland Schmieder; Salim 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Pioglitazone and the risk of cardiovascu

Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin–angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20)

✍ Erland ERDMANN; Robert SPANHEIMER; Bernard CHARBONNEL; on behalf of the PROactiv 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

Efficacy and Safety of Rosuvastatin 40 m

Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study)

✍ Christie M. Ballantyne; Robert Weiss; Tiziano Moccetti; Anja Vogt; Bernd Eber; F 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 133 KB